- Report
- November 2025
- 150 Pages
Japan
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- November 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
China
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
China
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- March 2024
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- October 2024
- 70 Pages
North America
From €832EUR$950USD£722GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €832EUR$950USD£722GBP
- Report
- October 2024
- 70 Pages
Latin America
From €832EUR$950USD£722GBP
- Report
- October 2024
- 70 Pages
China
From €832EUR$950USD£722GBP
- Report
- October 2024
- 70 Pages
France
From €832EUR$950USD£722GBP
- Report
- October 2024
- 70 Pages
Germany
From €832EUR$950USD£722GBP
- Report
- October 2024
- 70 Pages
India
From €832EUR$950USD£722GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €832EUR$950USD£722GBP
- Report
- October 2024
- 70 Pages
United States
From €832EUR$950USD£722GBP
- Report
- October 2025
- 84 Pages
Oman
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 88 Pages
Bahrain
From €4248EUR$4,850USD£3,687GBP
- Report
- August 2024
- 62 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- July 2024
- 127 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- July 2024
- 109 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- July 2024
- 114 Pages
Global
From €3500EUR$4,281USD£3,144GBP

Biomarker Analytics is a rapidly growing field within the larger field of Biomarkers. It involves the use of advanced analytics to identify, measure, and interpret biological markers in order to gain insights into the health of individuals and populations. This includes the use of data from clinical trials, medical records, and other sources to identify biomarkers that can be used to diagnose and treat diseases. Biomarker Analytics also involves the development of predictive models to identify individuals at risk for certain diseases and to monitor the progression of diseases.
The Biomarker Analytics market is driven by the increasing demand for personalized medicine and the need for more accurate and cost-effective diagnostics. Companies in this market include Illumina, Qiagen, Thermo Fisher Scientific, Roche, and Agilent Technologies. Show Less Read more